Author + information
- Apurva Patel1,
- Roosha Parikh2,
- Samuel Kolman3,
- Jeffrey Ma4,
- Justin Ratcliffe5,
- Joseph Puma6 and
- Tak Kwan7
- 1Mount Sinai Beth Israel, New York, New York, United States
- 2Unknown, Towaco, New Jersey, United States
- 3Kobe University Hospital
- 4Hospital Universitari Germans Trias i Pujol, Hemodynamic Department, Badalona, Spain
- 5Beth Israel Medical Center, New York, New York, United States
- 6ApexNano Medical
- 7Mount Sinai Beth Israel, New York, New York, United States
For patients suffering from peripheral arterial disease (PAD), quality of life (QOL) is as important as mortality, morbidity and amputation, to evaluate the effect of disease and treatment. There is paucity of data to support single tibial vessel intervention for tibial occlusive disease. We report a first ever QOL data for endovascular single tibial vessel intervention via transpedal access.
Prospective analysis was performed of 36 consecutive patients with lifestyle limiting claudication who underwent single tibial vessel intervention via transpedal access (anterior (AT) or posterior tibial (PT), peroneal or dorsalis pedis (DP)) between 03/2016 and 05/2016. The validated Walking Impairment Questionnaire (WIQ) was completed by all patients at baseline and 30 days after treatment.
A total of 36 patients (97% Rutherford Class 3-4, 3% class 5, age 70 ± 10 yrs, male 40%, hypertension 81%, smoker 28%, diabetes 56%) underwent single tibial vessel intervention (AT 72%, PT 19%, peroneal 9%, orbital atherectomy/balloon angioplasty 100%). After the intervention, there was a significant improvement in the WIQ score (6330.5 vs 6550.7, p=0.006) (Figure). On evaluating the individual components of WIQ, there was significant improvement in walking impairment (6288.61 vs 6995.83 p=0.013) and symptoms (18.8 vs 20.3, p=0.012).
Patients with tibial PAD with persistent lifestyle-limiting claudication despite maximal medical therapy can benefit from single tibial vessel intervention. Significant improvement in QOL is reported based on 30 day post-procedure Walking Impairment Questionnaire data.
ENDOVASCULAR: Peripheral Vascular Disease and Intervention